ViroPharma, Inc. (NASDAQ:VPHM)

CAPS Rating: 4 out of 5

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Recs

0
Player Avatar 2trpop (30.91) Submitted: 1/17/2012 9:18:28 AM : Outperform Start Price: $29.56 VPHM Score: +5.14

momentum play

Featured Broker Partners


Advertisement